INTENDED USE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
GLP-2 Tirzep – Research Use Only
Description:
Tirzepatide is a synthetic peptide under active investigation as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. Research suggests that Tirzepatide may influence multiple metabolic pathways, with studies focusing on glucose regulation, body weight management, and insulin sensitivity. Because it targets two incretin receptors, it has gained strong interest in metabolic and obesity-related research.
Background:
Developed as part of incretin-based research, Tirzepatide is unique due to its dual receptor activity, unlike many other GLP-1 analogues that act on a single pathway. By engaging both GIP and GLP-1 receptors, it has shown promising results in laboratory and clinical research for regulating glucose homeostasis and supporting metabolic health models.
Potential Areas of Research:
Dual receptor agonism (GIP + GLP-1) and metabolic regulation
Effects on glucose control and insulin sensitivity
Impact on weight management in obesity models
Cardiovascular and metabolic biomarker studies
Comparative research with other GLP-1 receptor agonists
Molecular Formula: C₂₂₅H₃₆₃N₄₃O₇₀
Molecular Weight: ~4813 g/mol
Sequence: Proprietary sequence based on GIP/GLP-1 analog modifications
Disclaimer:
This compound is provided strictly for laboratory research purposes only. It is not intended for human consumption, medical use, or veterinary use.